Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Retained Earnings	Noncontrolling interest
Beginning balance (in shares) at Dec. 31, 2021		131,161,404
Beginning balance at Dec. 31, 2021	$ 1,431,849	$ 13	$ 1,571,535	$ (1,099)	$ (138,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with a grant agreement (in shares)		881,365
Issuance of common stock in connection with a grant agreement	28,462		28,462
Vesting of restricted common stock (in shares)		270,598
Exercise of stock option (in shares)		190,270
Exercise of stock options	1,558		1,558
Issuance of common stock under employee stock purchase plan (in shares)		94,175
Issuance of common stock under employee stock purchase plan	2,066		2,066
Stock-based compensation	52,403		52,403
Other comprehensive income	(6,454)			(6,454)
Net (loss) income	442,128				442,128
Ending balance at Jun. 30, 2022	1,952,012	$ 13	1,656,024	(7,553)	303,528	$ 0
Ending balance (in shares) at Jun. 30, 2022		132,597,812
Beginning balance (in shares) at Mar. 31, 2022		132,353,441
Beginning balance at Mar. 31, 2022	2,001,014	$ 13	1,625,785	(4,805)	380,021	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		53,712
Exercise of stock option (in shares)		96,484
Exercise of stock options	1,074		1,074
Issuance of common stock under employee stock purchase plan (in shares)		94,175
Issuance of common stock under employee stock purchase plan	2,066		2,066
Stock-based compensation	27,099		27,099
Other comprehensive income	(2,748)			(2,748)
Net (loss) income	(76,493)				(76,493)
Ending balance at Jun. 30, 2022	$ 1,952,012	$ 13	1,656,024	(7,553)	303,528	0
Ending balance (in shares) at Jun. 30, 2022		132,597,812
Beginning balance (in shares) at Dec. 31, 2022	133,236,687	133,236,687
Beginning balance at Dec. 31, 2022	$ 2,077,963	$ 13	1,709,835	(9,122)	377,237
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		617,460
Exercise of stock option (in shares)		261,444
Exercise of stock options	3,052		3,052
Issuance of common stock under employee stock purchase plan (in shares)		114,903
Issuance of common stock under employee stock purchase plan	2,605		2,605
Stock-based compensation	56,100		56,100
Contributions from noncontrolling interest owners	100					100
Other comprehensive income	6,219			6,219
Increase in ownership interest in a subsidiary	(100)		(56)			(44)
Net (loss) income	(335,731)				(335,675)	(56)
Ending balance at Jun. 30, 2023	$ 1,810,208	$ 13	1,771,536	(2,903)	41,562	0
Ending balance (in shares) at Jun. 30, 2023	134,230,494	134,230,494
Beginning balance (in shares) at Mar. 31, 2023		133,930,957
Beginning balance at Mar. 31, 2023	$ 1,970,801	$ 13	1,737,626	(3,219)	236,337	44
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		100,292
Exercise of stock option (in shares)		84,342
Exercise of stock options	742		742
Issuance of common stock under employee stock purchase plan (in shares)		114,903
Issuance of common stock under employee stock purchase plan	2,605		2,605
Stock-based compensation	30,619		30,619
Other comprehensive income	316			316
Increase in ownership interest in a subsidiary	(100)		(56)			(44)
Net (loss) income	(194,775)				(194,775)
Ending balance at Jun. 30, 2023	$ 1,810,208	$ 13	$ 1,771,536	$ (2,903)	$ 41,562	$ 0
Ending balance (in shares) at Jun. 30, 2023	134,230,494	134,230,494